🔬Deep Research

ANNX — Annexon Inc · catalysts, narrative & risks

·16 sourcesANNX forecast →

Annexon Inc. (ANNX) — Catalyst, Narrative, Risk, and Calendar Review

As of 2026-10-04. Not investment advice.

Recent catalysts (roughly July–October 2026)

Annexon's activity has been dominated by its two late-stage programs in Guillain-Barre Syndrome (GBS) and geographic atrophy (GA):


AI-assisted research from the K3vl4r desk — not personalized investment advice. More research →